GMED - Globus Medical - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GMED is currently covered by 13 analysts with an average price target of $73.24. This is a potential upside of $12.85 (21.28%) from yesterday's end of day stock price of $60.39.

Globus Medical's activity chart (see below) currently has 301 price targets and 230 ratings on display. The stock rating distribution of GMED is 55.56% BUY, 2.78% SELL and 41.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 92.18% with an average time for these price targets to be met of 299.24 days.

Highest price target for GMED is $115, Lowest price target is $68, average price target is $89.5.

Most recent stock forecast was given by WILLIAM PLOVANIC from CANACCORD on 22-Jul-2025. First documented stock forecast 17-Jun-2013.

Currently out of the existing stock ratings of GMED, 20 are a BUY (55.56%), 1 are a SELL (2.78%), 15 are a HOLD (41.67%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$90

$29.61 (49.03%)

$101

3 months 11 days ago
(22-Jul-2025)

3/5 (60%)

$36.99 (69.78%)

255

Hold

3 months 12 days ago
(21-Jul-2025)

3/3 (100%)

$10.44 (17.24%)

499

Hold

5 months 6 days ago
(27-May-2025)

1/1 (100%)

$4.73 (18.01%)

469

Hold

$91

5 months 6 days ago
(27-May-2025)

15/15 (100%)

$8.29 (10.02%)

133

Hold

$68

$7.61 (12.60%)

$80

5 months 21 days ago
(12-May-2025)

24/28 (85.71%)

$8.99 (15.23%)

347

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GMED (Globus Medical) average time for price targets to be met?

On average it took 299.24 days on average for the stock forecasts to be realized with a an average price target met ratio 92.18

Which analyst has the current highest performing score on GMED (Globus Medical) with a proven track record?

JASON WITTES

Which analyst has the most public recommendations on GMED (Globus Medical)?

Jason Wittes has 10 price targets and 8 ratings on GMED

Which analyst is the currently most bullish on GMED (Globus Medical)?

Jason Wittes with highest potential upside - $54.61

Which analyst is the currently most reserved on GMED (Globus Medical)?

Steven Lichtman with lowest potential downside - -$37.39

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?